Literature DB >> 26058476

Silent cerebral infarcts in very young children with sickle cell anaemia are associated with a higher risk of stroke.

Maria I Cancio1, Kathleen J Helton2, Jane E Schreiber3, Matthew P Smeltzer4,5, Guolian Kang4, Winfred C Wang1.   

Abstract

Silent cerebral infarctions (SCI) are the most common neurological injury in children with sickle cell anaemia (SCA), but their incidence/prognosis in early childhood has not been well described. We report clinical, neuroradiological, psychometric and academic follow-up over an average period of 14 years in 37 children with SCA who had magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA) of the brain between ages 7 and 48 months. Ten patients (27%) younger than age 5 years (Group I) had SCI, as did 12 (32%) older than 5 years (Group II). Fifteen (41%) had no lesions (Group III). Overt stroke or transient ischaemic attack occurred in 5/9 (56%) in Group I. Most Group I patients had progressive MRI abnormalities, concurrent stenosis, decreased cognitive ability, attention/executive function deficits and hindered academic attainment. The proportions of subjects in Group I with subsequent neurological events (P ≤ 0·006), progressive ischaemia (P ≤ 0·001) and vascular stenosis (P ≤ 0·006) were greater than in Groups II and III. Thus, SCI in young children with SCA may predict overt central nervous system events, progressive MRI abnormalities, stenosis, cognitive dysfunction and poor academic performance. Children younger than 5 years may benefit from MRI/MRA testing and should be considered for aggressive intervention when SCI are detected.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  magnetic resonance imaging; sickle cell anaemia; silent cerebral infarction; stroke

Mesh:

Year:  2015        PMID: 26058476     DOI: 10.1111/bjh.13525

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  12 in total

Review 1.  New insights into sickle cell disease: mechanisms and investigational therapies.

Authors:  Gregory J Kato
Journal:  Curr Opin Hematol       Date:  2016-05       Impact factor: 3.284

Review 2.  Advances in Understanding Ischemic Stroke Physiology and the Impact of Vasculopathy in Children With Sickle Cell Disease.

Authors:  Kristin P Guilliams; Melanie E Fields; Michael M Dowling
Journal:  Stroke       Date:  2019-02       Impact factor: 7.914

Review 3.  Neurologic complications in children under five years with sickle cell disease.

Authors:  Aisha A Galadanci; Michael R DeBaun; Najibah A Galadanci
Journal:  Neurosci Lett       Date:  2019-04-27       Impact factor: 3.046

Review 4.  Sickle Cell Disease and Stroke: Diagnosis and Management.

Authors:  Courtney Lawrence; Jennifer Webb
Journal:  Curr Neurol Neurosci Rep       Date:  2016-03       Impact factor: 5.081

5.  Progression of central nervous system disease from pediatric to young adulthood in sickle cell anemia.

Authors:  Grace Champlin; Scott N Hwang; Andrew Heitzer; Juan Ding; Lisa Jacola; Jeremie H Estepp; Winfred Wang; Kenneth I Ataga; Curtis L Owens; Justin Newman; Allison A King; Robert Davis; Guolian Kang; Jane S Hankins
Journal:  Exp Biol Med (Maywood)       Date:  2021-08-18

6.  Asymmetric Dimethylarginine Levels and Its Correlation to Cerebral Blood Flow in Children with Sickle Cell Anemia.

Authors:  Mohamed El-Shanshory; Nahed Hablas; Hala Nagy; Naglaa Fathy
Journal:  Indian J Hematol Blood Transfus       Date:  2019-03-13       Impact factor: 0.900

7.  Sociodemographic and Biomedical Correlates of Developmental Delay in 2- and 4-Year-Olds with Sickle Cell Disease.

Authors:  Jeffrey Schatz; Laura Reinman; Sarah E Bills; Julia D Johnston
Journal:  J Dev Behav Pediatr       Date:  2021-09-24       Impact factor: 2.988

8.  Vascular Instability and Neurological Morbidity in Sickle Cell Disease: An Integrative Framework.

Authors:  Hanne Stotesbury; Jamie M Kawadler; Patrick W Hales; Dawn E Saunders; Christopher A Clark; Fenella J Kirkham
Journal:  Front Neurol       Date:  2019-08-13       Impact factor: 4.003

9.  Silent cerebral infarcts in patients with sickle cell disease: a systematic review and meta-analysis.

Authors:  Maite E Houwing; Rowena L Grohssteiner; Marjolein H G Dremmen; Ferdows Atiq; Wichor M Bramer; Anne P J de Pagter; C Michel Zwaan; Tonya J H White; Meike W Vernooij; Marjon H Cnossen
Journal:  BMC Med       Date:  2020-12-22       Impact factor: 8.775

10.  Pediatric Neurodevelopmental Delays in Children 0 to 5 Years of Age With Sickle Cell Disease: A Systematic Literature Review.

Authors:  La'Kita M J Knight; Allison A King; John J Strouse; Paula Tanabe
Journal:  J Pediatr Hematol Oncol       Date:  2021-04-01       Impact factor: 1.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.